Director, Oncology Clinical Affairs (MD)

Responsibilities:

Clinical Engagement and Support

Partner with Medical Affairs leadership to support the execution of medical priorities related to product adoption and long-term integration into clinical practice. Serve as the primary clinical bridge between Clinical Development and go-to-market teams, ensuring clinical expertise is available to support Medical Affairs, Commercial, Market Access, HEOR, and Regulatory activities
Provide clinical and medical/scientific expertise to support medical affairs priorities, tactical planning, internal training, advisory boards, congress activities, and cross-functional initiatives that advance product adoption and integration into clinical practice
Identify areas of unmet medical need and work cross-functionally to translate scientific insights into practical clinical guidance that supports physicians, patients, and internal decision-making
Model and promote Corcept’s key principles, collaborating effectively, embracing possibilities, following the data, and leading by doing, to build a culture of accountability, innovation, and trust

Scientific Engagement and External Leadership

Lead high-level peer-to-peer scientific interactions with oncology experts, key opinion leaders (KOLs), clinical researchers, academic centers, and other external medical stakeholders
Build credibility through balanced scientific exchange around the company’s assets, disease areas, emerging data, unmet needs, and evolving standards of care
Engage physicians and oncology experts through advisory boards, congress interactions, speaker preparation, and insight-gathering activities to inform medical strategy, education, publications, and evidence planning
Represent Corcept at key medical conferences and external events as an internal clinical expert and external medical ambassador

Evidence Generation and Data Communication

Provide clinical input to post-approval evidence generation activities, including real-world evidence (RWE), investigator sponsored studies (ISS), registries, and other data-generation activities that address clinically meaningful evidence gaps
Provide clinical review and input into ISS proposals and collaborate with Medical Affairs partners on program design, prioritization, and governance
Evaluate scientific data, clinical trial results, post-marketing evidence, medical literature, and emerging oncology practice trends to inform internal strategy and external scientific communications
Support development of accurate, balanced, and compliant scientific, educational, medical information, and promotional review materials in partnership with Medical, Legal, Regulatory, Commercial, and Compliance stakeholders

Guideline, Pathway, and Payer-Facing Scientific Support

Provide perspectives in interpreting, anticipating, and influencing clinical guideline updates and treatment pathways, including NCCN, ASCO, and other relevant oncology contexts
Engage external experts and stakeholders to support appropriate representation of the company’s data in guidelines and treatment pathways translate guideline and pathway changes into clear clinical and business-relevant implications for internal teams
Partner with Market Access and HEOR teams to align the clinical narrative with payer value propositions, including outcomes, comparative effectiveness, and economic value
Participate in payer-facing discussions when deep clinical expertise is required, ensuring scientific alignment, balanced communication, and compliance with internal standards

Safety and Supportive Care Guidance

Partner with Pharmacovigilance, Clinical Development, and Medical Affairs to develop, refine, and communicate safety-related clinical guidance for assigned asset(s)
Translate emerging safety data, post-marketing reports, and clinical trial safety findings into practical clinician-facing recommendations, including monitoring strategies, risk mitigation approaches, and adverse event management algorithms
Contribute to supportive care guidance that optimizes patient tolerability and continuity of therapy while aligning with regulatory requirements, internal safety governance, and real-world oncology practice
Support safety-related external communications, including responses to KOL inquiries, advisory boards, congress interactions, and other scientific exchanges, while ensuring consistency, balance, and compliance

Preferred Skills, Qualifications and Technical Proficiencies:

Demonstrated ability to evaluate scientific data, clinical literature, evolving treatment pathways, and oncology practice trends and apply insights to medical, launch, market access, and evidence-generation activities
Understanding of the U.S. healthcare environment, health technology assessment (HTA) considerations, payer evidence needs, and the pharmaceutical/biotechnology industry
Strong oral, written, and presentation skills, with the ability to communicate complex clinical concepts clearly to internal and external audiences
Collaborative, cross-functional leadership style with sound judgment, scientific rigor, and the ability to operate effectively in a launch-focused, evolving environment
Ability to travel 25-30% or as needed
Demonstrated ability to evaluate scientific data, clinical literature, evolving treatment pathways, and oncology practice trends and apply insights to medical, launch, market access, and evidence-generation activities
Understanding of the U.S. healthcare environment, health technology assessment (HTA) considerations, payer evidence needs, and the pharmaceutical/biotechnology industry
Strong oral, written, and presentation skills, with the ability to communicate complex clinical concepts clearly to internal and external audiences
Collaborative, cross-functional leadership style with sound judgment, scientific rigor, and the ability to operate effectively in a launch-focused, evolving environment
Ability to travel 25-30% or as needed
MD required
Oncology experience required; gynecologic oncology experience preferred
3-5+ years of relevant oncology practice (including fellowship)
Experience engaging oncology experts, interpreting clinical evidence, and translating complex data into clear scientific and clinical communications